Clinical Trials Logo
  1. Home
  2. Fetal Alcohol Spectrum Disorders
  3. NCT04918043
  4. Details
NCT04918043 Clinical Trial

Alcohol Use During Pregnancy in Finland According to Meconium Samples

Fetal Alcohol Spectrum Disorders Clinical Trial

— RASMEK21  

Official title:
Raskaudenaikaiset Elintavat ja Etyyliglukuronidin Esiintyminen Mekoniumissa Suomessa

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04918043
Other study ID # HUS/222/2021
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 1, 2021
Est. completion date August 30, 2021

Study information
Verified date May 2021
Source Helsinki University Central Hospital
Contact Mikko Koivu-Jolma
Phone +358414873836
Email mikko.koivu-jolma@helsinki.fi
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Meconium samples are collected anonymously from newborns in Helsinki University Hospital maternity ward. The study tries to to find how many women continue to use alcohol during the second half of the pregnancy. Meconium samples are tested for ethylglucuronide (EtG), a metabolite of ethanol, that accumulates in the meconium. Altogether 1000 samples are taken. The sample results are compared to anonymously answered questionnaire about alcohol use.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 1000
Est. completion date August 30, 2021
Est. primary completion date August 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 3 Days
Eligibility Inclusion Criteria: - newborn baby Exclusion Criteria: -

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
n/a

Sponsors (3)
Lead Sponsor Collaborator
Hanna Kahila Helsinki University Central Hospital, Lastentautien tutkimussäätiö

Outcome
Type Measure Description Time frame Safety issue
Primary EtG The meconium samples from newborns are tested for ethyl glucuronide using LC-MS/MS mass spectrometry. Once
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Completed NCT01961050 - Preventing FAS/ARND in Russian Children N/A
Recruiting NCT05108974 - Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study Phase 2
Completed NCT02457676 - Improving Self Regulation in Children With Fetal Alcohol Syndrome Spectrum Disorders: A Neuroplastic Intervention N/A
Recruiting NCT06005181 - The Synchrony Study: Examining Music Training for Children With FASD N/A
Completed NCT04571463 - Ethyl Glucuronide in Urine Samples of Pregnant Women Within the HUS ja PHHYKY Area
Completed NCT03361293 - Cognitive Training and tDCS for Children With FASD N/A
Recruiting NCT05534568 - The Oklahoma Parent-Child Assistance Program N/A
Recruiting NCT05456321 - CIFASD 5 tDCS and Cognitive Training N/A
Completed NCT01911299 - Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders Phase 2
Recruiting NCT04332172 - Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy N/A
Completed NCT05604014 - Feasibility Study of the My Health Coach App for Adults With FASD N/A
Recruiting NCT05960461 - Families Moving Forward (FMF) Connect Pro for Mental Health Providers N/A
Terminated NCT03852550 - READYorNot[TM] Brain-Based Disabilities Trial N/A
Completed NCT02735473 - Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Phase 2
Completed NCT03782935 - Nutritional Risk Factors for FASD in Ukraine N/A
Completed NCT04072809 - Dissecting the Genetics of Fetal Alcohol Spectrum Disorders
Completed NCT01149538 - Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure Phase 1/Phase 2
Completed NCT05028517 - Efficacy Trial of the FMF Connect Mobile Health Intervention N/A
Completed NCT04194489 - Trial of the Families Moving Forward (FMF) Connect Mobile Health Intervention N/A